Stay updated on Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial

Sign up to get notified when there's something new on the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed, replacing the previous Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T00:30:38.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Added Related topics entries for Non-alcoholic fatty liver disease and MedlinePlus Genetics on the study page.
    Difference
    0.1%
    Check dated 2026-02-25T18:32:52.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Removed the term 'Non-alcoholic fatty liver disease' from the page's conditions/topics and deleted the related topic link to MedlinePlus Genetics.
    Difference
    0.1%
    Check dated 2026-02-18T16:34:37.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed Revision: v3.4.1 and a maintenance notice. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T11:36:14.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    A funding-status notice was added at the top of the page, and the site version was updated from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T10:15:46.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    Added a Show glossary toggle and a new 'Last Update Submitted that Met QC Criteria' timestamp. Updated the footer to 'No FEAR Act data' capitalization and bumped the page revision to v3.4.0, replacing the previous 'Last Update Submitted that met QC Criteria' label.
    Difference
    0.2%
    Check dated 2026-01-28T05:55:42.000Z thumbnail image

Stay in the know with updates to Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page.